Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases

Basal cell carcinoma (BCC) is the most common skin cancer worldwide. The WHO has defined it as “a locally invasive, slowly spreading tumor which rarely metastasizes, arising in the epidermis or hair follicles and in which the peripheral cells usually simulate the basal cells of the epidermis.” Here...

Full description

Saved in:
Bibliographic Details
Main Authors: Jagdeep Rao, Harsh Deora
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2014/320792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545455863496704
author Jagdeep Rao
Harsh Deora
author_facet Jagdeep Rao
Harsh Deora
author_sort Jagdeep Rao
collection DOAJ
description Basal cell carcinoma (BCC) is the most common skin cancer worldwide. The WHO has defined it as “a locally invasive, slowly spreading tumor which rarely metastasizes, arising in the epidermis or hair follicles and in which the peripheral cells usually simulate the basal cells of the epidermis.” Here we discuss the management of BCCs of central face with surgical excision and reconstruction with forehead flap as single modality treatment. Material and Methods. This is a retrospective review of 50 patients who underwent surgical excision of BCC involving the facial region followed by primary reconstruction using forehead flaps at a single institution. There were 20 males and 30 females, mean age of 59 years. Results. No recurrence at primary site was observed during the follow-up of 1–4 yrs. There was no ectropion or exposure sequela. However, epiphora was evident. Size of lesions ranged from 2 to 6 cm. Keloid formation was seen in 2 (4%) patients. Functional and cosmetic outcomes were satisfactory. Conclusion. For the face, the best reconstructive effort eventually fails in the face of tumor recurrence. The forehead flap represents one of the best methods for repair of extensive facial defects. Complete tumor extirpation, the primary event, is the key.
format Article
id doaj-art-92e0b6682e274856b80c4f46f3f7d998
institution Kabale University
issn 2090-2905
2090-2913
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Skin Cancer
spelling doaj-art-92e0b6682e274856b80c4f46f3f7d9982025-02-03T07:25:50ZengWileyJournal of Skin Cancer2090-29052090-29132014-01-01201410.1155/2014/320792320792Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 CasesJagdeep Rao0Harsh Deora1Department of Plastic Surgery, Sawai Man Singh Medical College, Jaipur, Rajasthan 300204, IndiaDepartment of General Surgery, Sawai Man Singh Medical College, Jaipur, Rajasthan 300204, IndiaBasal cell carcinoma (BCC) is the most common skin cancer worldwide. The WHO has defined it as “a locally invasive, slowly spreading tumor which rarely metastasizes, arising in the epidermis or hair follicles and in which the peripheral cells usually simulate the basal cells of the epidermis.” Here we discuss the management of BCCs of central face with surgical excision and reconstruction with forehead flap as single modality treatment. Material and Methods. This is a retrospective review of 50 patients who underwent surgical excision of BCC involving the facial region followed by primary reconstruction using forehead flaps at a single institution. There were 20 males and 30 females, mean age of 59 years. Results. No recurrence at primary site was observed during the follow-up of 1–4 yrs. There was no ectropion or exposure sequela. However, epiphora was evident. Size of lesions ranged from 2 to 6 cm. Keloid formation was seen in 2 (4%) patients. Functional and cosmetic outcomes were satisfactory. Conclusion. For the face, the best reconstructive effort eventually fails in the face of tumor recurrence. The forehead flap represents one of the best methods for repair of extensive facial defects. Complete tumor extirpation, the primary event, is the key.http://dx.doi.org/10.1155/2014/320792
spellingShingle Jagdeep Rao
Harsh Deora
Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
Journal of Skin Cancer
title Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
title_full Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
title_fullStr Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
title_full_unstemmed Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
title_short Surgical Excision with Forehead Flap as Single Modality Treatment for Basal Cell Cancer of Central Face: Single Institutional Experience of 50 Cases
title_sort surgical excision with forehead flap as single modality treatment for basal cell cancer of central face single institutional experience of 50 cases
url http://dx.doi.org/10.1155/2014/320792
work_keys_str_mv AT jagdeeprao surgicalexcisionwithforeheadflapassinglemodalitytreatmentforbasalcellcancerofcentralfacesingleinstitutionalexperienceof50cases
AT harshdeora surgicalexcisionwithforeheadflapassinglemodalitytreatmentforbasalcellcancerofcentralfacesingleinstitutionalexperienceof50cases